Jonathan C. Edwards, M.D., Director of MUSC's Comprehensive Epilepsy Center, who participated in the clinical trial that led to recent FDA approval of responsive neurostimulation (RNS) for partial epileptic seizure, discusses how RNS offers for the first time two-way communication with the brain. The RNS device first records seizure activity and, once the electronic signature of a patient's seizures is identified, is programmed to recognize and disrupt that signature.Read “Conversing with...